Periconceptional serum creatinine and risk of childhood autism spectrum disorder: a research letter
Harel Z, Jeyakumar N, Kang Y, Velez MP, Dayan N, Ray JG. Can J Kidney Health Dis. 2023; Dec 29 [Epub ahead of print].
Publications
Opioid agonist treatment retention among people initiating methadone and buprenorphine across diverse demographic and geographic subgroups in Ontario: a population-based retrospective cohort study
Elnagdi A, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B, Gomes T. Can J Addict. 2023; 14(4):p 44-54. Epub 2023 Dec 29.
Youth cannabis use and subsequent health service use for mood and anxiety disorders: a population-based cohort study
McDonald AJ, Kurdyak P, Rehm J, Roerecke M, Bondy SJ. Psychiatry Res. 2024; 332:115694. Epub 2023 Dec 25.
Initiation of opioid agonist therapy after hospital visits for opioid poisonings in Ontario
Hu T, McCormack D, Juurlink DN, Campbell TJ, Bayoumi AM, Leece P, Kent JT, Gomes T. CMAJ. 2023;
The PSY-SIM model: Using real-world data to inform healthcare policy for individuals with chronic psychotic disorders
de Oliveira C, Mason J, Luu L, Iwajomo T, Simbulan F, Kurdyak P, Pechlivanoglou P. Schizophr Bull. 2023; Dec 16 [Epub ahead of print].
Interpersonal trauma and discharge symptom severity among individuals with psychotic disorders: a population-based cohort study in Ontario
Behdinan T, Chen S, Gatov E, Chiu M, Saunders N, Lebenbaum M, Kurdyak P, Vigod SN. Eur J Trauma Dissociation. 2023; Dec 14 [Epub ahead of print].
Mortality in adolescents and young adults following a first presentation to the emergency department for alcohol
Harrison LD, Dumicho AY, Bader Eddeen A, Tanuseputro P, Kendall CE, Fiedorowicz JG, Rosic T, Fernando SM, McNaughton CD, Corace K, Kurdyak P, Beckerleg W, Webber C, Gardner W, Sood M, Myran DT.
Models of shared care for the management of psychotic disorder after first diagnosis in Ontario
Wiener JC, Rodrigues R, Reid J, Anderson KK. Can Fam Physician. 2023;
Socioeconomic status and access to mental health care: the case of psychiatric medications for children in Ontario Canada
Currie J, Kurdyak P, Zhang J. J Health Econ. 2024; 93:102841. Epub 2023 Dec 12.
Impact of non-medical cannabis legalization with market restrictions on health service use and incident cases of psychotic disorder in Ontario, Canada
Anderson KK, Rodrigues R, Le B, Mamun M, Archie S, Edwards J, Elton-Marshall T, Gilliland J, Myran DT, Palaniyappan L, Perlman CM, Seabrook JA, Murray RM, Shariff SZ. Int J Drug Policy. 2023; Dec 10 [Epub ahead of print].